NEW YORK (Reuters Health) – The interferon-gamma release assay (IGRA) is more specific, at least as sensitive, and may better predict disease progression than the tuberculin skin test…
NEW YORK (Reuters Health) – In a phase three study of elderly patients with newly diagnosed acute myeloid leukemia (AML), decitabine achieved a higher response rate, with a…
NEW YORK (Reuters Health) – Blood from patients with uncomplicated hemochromatosis is safe and effective for transfusion, researchers from the Belgian Red Cross report in the June 1st…
NEW YORK (Reuters Health) – Cap-assisted colonoscopy (CAC) shortens cecal intubation time but offers only a marginal benefit over standard colonoscopy for polyp detection, according to a systematic…
NEW YORK (Reuters Health) – A strategy that combines cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) provides acceptable long term survival for patients with pseudomyxoma peritonei of appendiceal…
NEW YORK (Reuters Health) – Implantation of a second transcatheter heart valve (THV-in-THV) is effective treatment for failed transcatheter aortic valve replacement (TAVR), according to a report in…
NEW YORK (Reuters Health) – Doxycycline treatment prompts amelioration of filarial lymphedema independent of active infection, researchers report in a May 18th on-line paper in Clinical Infectious Diseases.…
NEW YORK (Reuters Health) – Recombinant factor VIIa (rFVIIa) appears to be safe and effective when used for off-label indications in pediatric patients, according to a report from…
NEW YORK (Reuters Health) – Infliximab for inflammatory bowel disease (IBD) is not associated with an increased risk for serious infection, death, or malignancy, including lymphoma, according to…
NEW YORK (Reuters Health) – The antiarrhythmic dronedarone (Multag, Sanofi SA) should be used with caution, particularly in patients with cardiovascular risk factors, advise clinicians in a report…
